Skip to main content

no Condition

4
Pipeline Programs
3
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Dompé
DompéItaly - L'Aquila
3 programs
3
DF2755APhase 11 trial
Ketoprofen Lysine Salt combined with GabapentinPhase 11 trial
LadarixinPhase 11 trial
Active Trials
NCT04803396Terminated32Est. Jun 2019
NCT04802967Completed141Est. Apr 2022
NCT04854642Completed36Est. Dec 2020
Zambon
ZambonItaly - Bresso
1 program
1
N-acetylcysteinePhase 11 trial
Active Trials
NCT02265224Completed48Est. Sep 2014
CROSSJECT
CROSSJECTFrance - Dijon
2 programs
Intramuscular ZENEO® injectionN/A1 trial
Intramuscular ZENEO® injection of nominal strengthN/A1 trial
Active Trials
NCT03044301Completed97Est. Jun 2016
NCT03225638Unknown86Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
DompéKetoprofen Lysine Salt combined with Gabapentin
DompéLadarixin
DompéDF2755A
ZambonN-acetylcysteine
CROSSJECTIntramuscular ZENEO® injection of nominal strength
CROSSJECTIntramuscular ZENEO® injection

Clinical Trials (6)

Total enrollment: 440 patients across 6 trials

NCT04802967DompéKetoprofen Lysine Salt combined with Gabapentin

A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males

Start: Feb 2021Est. completion: Apr 2022141 patients
Phase 1Completed
NCT04854642DompéLadarixin

A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers

Start: Oct 2020Est. completion: Dec 202036 patients
Phase 1Completed
NCT04803396DompéDF2755A

Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A

Start: Nov 2018Est. completion: Jun 201932 patients
Phase 1Terminated
NCT02265224ZambonN-acetylcysteine

Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

Start: Sep 2014Est. completion: Sep 201448 patients
Phase 1Completed
NCT03225638CROSSJECTIntramuscular ZENEO® injection of nominal strength

Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)

Start: Sep 2017Est. completion: Dec 201786 patients
N/AUnknown
NCT03044301CROSSJECTIntramuscular ZENEO® injection

Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)

Start: Mar 2015Est. completion: Jun 201697 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.